Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 2.62% is 51% above its 1-year average of 1.74%, near the high end of its 1-year range (0.86%–2.62%).
As of the fiscal period ended Tuesday, June 30, 2026.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 2.62%.
RETURN ON EQUITY (ROE)
2.62%
RETURN ON EQUITY (ROE) AVG TTM
N/A
RETURN ON EQUITY (ROE) AVG 3Y
N/A
RETURN ON EQUITY (ROE) AVG 5Y
N/A
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · FINANCIAL SERVICES
8.51%
median of 624 covered companies
CURRENT VS SECTOR MEDIAN
-69.15%
vs the sector median at left
Drugs Made In America Acquisition II Corp. Ordinary Shares
Market Cap
$649.10M
Return on Equity (ROE)
2.62%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$649.93M
Return on Equity (ROE)
45.62%
TTM Avg
9.27%
3Y Avg
4.95%
5Y Avg
3.60%
Market Cap
$649.65M
Return on Equity (ROE)
13.35%
TTM Avg
11.47%
3Y Avg
13.92%
5Y Avg
15.35%
Market Cap
$645.11M
Return on Equity (ROE)
-4.70%
TTM Avg
4.89%
3Y Avg
6.43%
5Y Avg
7.62%
Market Cap
$652.31M
Return on Equity (ROE)
12.73%
TTM Avg
17.82%
3Y Avg
12.75%
5Y Avg
-231.02%
Market Cap
$653.01M
Return on Equity (ROE)
12.90%
TTM Avg
9.66%
3Y Avg
11.33%
5Y Avg
10.45%
Market Cap
$639.99M
Return on Equity (ROE)
-0.83%
TTM Avg
9.94%
3Y Avg
12.92%
5Y Avg
12.65%
Market Cap
$664.94M
Return on Equity (ROE)
N/A
TTM Avg
-15.20%
3Y Avg
-29.09%
5Y Avg
-64.23%
Market Cap
$663.64M
Return on Equity (ROE)
18.66%
TTM Avg
9.98%
3Y Avg
-27.41%
5Y Avg
-37.53%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) | $649.10M | 2.62% | N/A | N/A | N/A |
| Tiptree Inc. (TIPT)vs › | $649.93M | 45.62% | 9.27% | 4.95% | 3.60% |
| Capital Bancorp, Inc. (CBNK)vs › | $649.65M | 13.35% | 11.47% | 13.92% | 15.35% |
| New Mountain Finance Corporation (NMFC)vs › | $645.11M | -4.70% | 4.89% | 6.43% | 7.62% |
| CoinShares PLC Ordinary Shares (CSHR)vs › | $652.31M | 12.73% | 17.82% | 12.75% | -231.02% |
| ACNB Corporation (ACNB)vs › | $653.01M | 12.90% | 9.66% | 11.33% | 10.45% |
| Coastal Financial Corporation (CCB)vs › | $639.99M | -0.83% | 9.94% | 12.92% | 12.65% |
| Chaince Digital Holdings Inc. (CD)vs › | $664.94M | N/A | -15.20% | -29.09% | -64.23% |
| Root, Inc. (ROOT)vs › | $663.64M | 18.66% | 9.98% | -27.41% | -37.53% |
| BlackRock Multi-Sector Income Trust (BIT)vs › | $633.46M | 6.96% | 7.56% | 6.50% | 3.41% |
ROE
2.6%
ROA
2.5%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 2.62% |
| 2026-03-31 | 1.75% |
| 2025-12-31 | 0.86% |
